An acute respiratory infection (ARI) is the most common single reason for outpatient office visits and antibiotic prescriptions.1-5
More than 90% of patients who present to their healthcare providers with the most common symptom of an ARI—an acute cough—have a syndrome caused by a virus.6-7
Unnecessary use of antibiotics leads to antibiotic resistance, causing more than 25,000 deaths in the EU, and 700,000 globally.8-9 Antibiotic resistance results in costs over €1.5 billion in the EU and $20 billion in the U.S. annually.1-2,8
The first and only rapid, all-in-one point-of-care test device that can identify a clinically significant acute respiratory infection and differentiate viral from bacterial causes.
FebriDx® can be used to help triage patients at the point of care to reduce uncertainty and avoid unnecessary antibiotics.
Results within 10 minutes increases confidence in whether or not to prescribe an antibiotic.
All-in-one test device allows doctors or nurses to test during triage.
Instrument-free means no expensive equipment and a fully portable solution.
Highly sensitive/specific dual biomarker technology provides reliable differentiation of viral and bacterial infections.
Routine use of antibiotics for ARI should be evaluated for safety as well as efficacy. Up to 1 in 5 drug-related emergency department visits are due to adverse events from antibiotic use, and about 1 in 1,000 has a serious adverse event.1,3,13
Adverse events resulting from unnecessary antibiotic prescriptions increase medical burden, healthcare costs, and expose patients to additional risks.12
When evaluating a patient with ARI symptoms, there is no evidence of benefit from antibiotics for the common cold or acute rhinitis in children or adults. There is evidence that antibiotics cause significant adverse effects in all ages when given for these conditions.14-15
Clostridium difficile (C. difficile) is a spore-forming bacteria that can produce a toxin causing symptoms ranging from mild diarrhoea to death.16-17 The estimated cost of this infection in Europe is €3 billion per year.18 It is associated with increased mortality and length of stay in hospitalized patients.18 The most important risk factor for C. difficile infection is previous antibiotic use.16-18 By eliminating unnecessary antibiotics and with continued antibiotic stewardship efforts, C. difficile rates can be reduced.16-17
COMMON
DIARRHOEA
NAUSEA
VOMITING
RASH
UPSET STOMACH
FUNGAL/YEAST INFECTIONS
C. difficile INFECTIONS
LESS COMMON
KIDNEY STONES
ABNORMAL BLOOD CLOTTING
SUN SENSITIVITY
BLOOD DISORDERS
DEAFNESS
SEVERE BLOODY DIARRHOEA
ALLERGIES (IMMEDIATE OR DELAYED)
RASH
SWELLING OF THE TONGUE
SWELLING OF THE FACE
DIFFICULTY BREATHING
Patients often insist on antibiotics. Since most coughs are caused by viral infections, antibiotics can often be prescribed unnecessarily.6-7 Using FebriDx® can help you explain why your patient may or may not need antibiotics, thereby improving patient satisfaction and confidence in their treatment recommendations.
HOW DO YOU KNOW
IF THEY NEED ANTIBIOTICS?
FEBRIDX® CAN PROVIDE HIGHLY ACCURATE RESULTS WITHIN THAT TIME PERIOD.
